Comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 vs 4 5 Toe Syndactyly C1837836
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Maternal Derived Androgen and 4 5 Toe Syndactyly for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
A condition where androgens from the pregnant person cross to the fetus, causing atypical genital development in an XX baby. It ranges from mild to severe. Specialists guide hormone and surgical management.
4 5 Toe Syndactyly C1837836
Fusion of the 4th and 5th toes, present from birth. May affect balance or cause difficulty with footwear. Surgery can separate the toes if needed.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
0-0
4 5 Toe Syndactyly C1837836
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
severe
4 5 Toe Syndactyly C1837836
mild
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
Chronic
4 5 Toe Syndactyly C1837836
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
No
4 5 Toe Syndactyly C1837836
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
reproductive
4 5 Toe Syndactyly C1837836
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
endocrine
4 5 Toe Syndactyly C1837836
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-maternal-derived-androgen-C5680197 and 4-5-toe-syndactyly-C1837836 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 4 5 Toe Syndactyly C1837836 | Discriminating power |
|---|---|---|---|
| Primary site | Atypical external genital development in an XX infant | Skin or soft-tissue fusion of the fourth and fifth toes | High |
| Functional concern | Possible hormone, fertility, and psychosocial issues; range varies | Possible footwear difficulty or mild balance issues | High |
| Associated system | Reproductive and endocrine evaluation is central | Musculoskeletal appearance is the main finding | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 when
XX infant with atypical genitalia and suspected maternal androgen exposure
The supplied description matches genital development rather than toe fusion
High
Need for endocrine and multidisciplinary DSD assessment
Hormone and specialist guidance are described for this condition
Moderate
Concern about long-term reproductive or psychosocial care
Management may extend beyond a localized congenital finding
Moderate
Choose 4 5 Toe Syndactyly C1837836 when
Newborn with fused fourth and fifth toes and typical genital findings
The finding is localized to the foot
High
Footwear rubbing or mild gait concern from toe fusion
These functional issues are described for syndactyly
Moderate
Considering toe separation only if function or comfort warrants it
Surgery is optional rather than routinely required
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 4 5 Toe Syndactyly C1837836 | Interpretation |
|---|---|---|---|
| Physical examination | Atypical genital anatomy may be present | Fourth–fifth toe fusion is visible | Exam site usually separates the findings; clinician confirmation is required |
| Karyotype or sex-chromosome testing | 46,XX is part of the named condition | No specific chromosomal result is established here | Do not infer a diagnosis from one test alone |
| Endocrine assessment | May help evaluate androgen exposure; cutoffs are not supplied | Not routinely indicated for isolated toe fusion | Abnormal hormone results are not themselves a complete diagnosis |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
- Outcome
- Variable and potentially complex; exact outcomes are not established
- Factors
- Degree of androgen effect and individualized endocrine or surgical care
4 5 Toe Syndactyly C1837836
- Outcome
- Often mild, with function commonly preserved
- Factors
- Extent of fusion, footwear problems, and whether surgery is chosen
Time frame: Both are present from birth and may need long-term follow-up
Clinician assessment should guide prognosis because source evidence is limited
Complications comparison
| Complication | Presentation |
|---|---|
| Local function | Genital and urinary function may need specialist review Walking, balance, or shoe fit may be affected Impact ranges and exact rates are not established |
| Intervention burden | Hormone care and possible surgery require individualized decisions Separation surgery may be considered if needed Neither intervention is universally required by these data |
| Associated findings | Broader endocrine causes should be excluded by clinicians Other limb anomalies are not established by this description Sparse source data limit complication claims |
Patient education highlights
- HighDifferent conditions
Atypical genital development and toe fusion involve different body systems and should not be treated as one diagnosis.
- HighSpecialist care
DSD evaluation belongs with experienced clinicians; syndactyly care focuses on comfort, footwear, and function.
- MediumAvoid unsupported numbers
Prevalence, laboratory cutoffs, mortality, and medication doses are not established here.